Ignite Creation Date:
2024-10-25 @ 8:01 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06541613
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-21
Brief Title:
Bilateral External Oblique Intercostal Plane Block in Laparoscopic Cholecystectomy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Bilateral External Oblique Intercostal Plane Block EOIPB an Alternative Analgesic Technique in Patients Scheduled for Laparoscopic Cholecystectomy A Randomized Controlled Study
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Pain after laparoscopic cholecystectomy LC is a common complaint that prolongs hospital stay and thus increases morbidity There are three primary sources of pain after LC incision site local and systemic effects of pneumoperitoneum and post cholecystectomy wound to the liver External oblique intercostal plane block EOIPB has recently been described as a novel block for upper abdomen surgery the probable mechanism of the block with the dyeing of both the anterior and lateral branches of the intercostal nerves T7-T10 This block also provides a dermatomal sensory block at the T6-T10 level in the anterior axillary region and the T6-T9 level in the midline
Detailed Description:
EOIPB has the benefit of being performed with the patient supine when compared with QLB and ESPB It also has an advantage over SIPB in that it produces greater analgesia throughout the midline of the abdomen The hypothesis of this randomized study is that patients who will undergo EOIPB will have lower opioid consumption in the postoperative period than patients who receive routine multimodal analgesia alone The study aims to assess pain control in the immediate postoperative period by assessment of Numerical Rating scale NRS time for the first analgesic request as well as total morphine intake in the first 24 hours after surgery
Study design
This is a prospective randomized double blinded control study which will be conducted in department of anesthesia and surgical Intensive care unit at Theodor Bilharz Research Institute after approval by research ethics committee and patient informed consent 50 patients will be enrolled in the study and divided into two groups either EOIPB group E or Control group C Randomization will be done by allocation 11 of scheduled cases per day
Sample size 38 patients
Study design
This is a prospective randomized double blinded control study which will be conducted in department of anesthesia and surgical Intensive care unit at Theodor Bilharz Research Institute after approval by research ethics committee and patient informed consent 50 patients will be enrolled in the study and divided into two groups either EOIPB group E or Control group C Randomization will be done by allocation 11 of scheduled cases per day
Sample size 38 patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None